A cell-permeable antitumor antibiotic. A stereoisomer of Doxorubicin (Cat. No. 324380) that exhibits reduced cardiotoxicity. Its antitumor actions are mediated by targeting topoisomerase II.
| Product information | |||
|---|---|---|---|
| Form | Orange-red solid | ||
| Molar mass | 580.0 | ||
| Protect from Light | Yes | ||
| Hygrocopic | Yes | ||
| Cell permeable | Yes | ||
| Purity | ≥95% by HPLC | ||
| Solubility | H2O | ||
| Chemical formula | C27H29NO11 · HCl | ||
| RTECS | QI9295750 | ||
| CAS number | 56390-09-1 | ||
| Merck USA index | 14, 3623 | ||
| Store and ship information | |||
|---|---|---|---|
| Storage | +2°C to +8°C | ||
| Ship |
Ambient Temperature Only
Harmful & Carcinogenic / Teratogenic |
||
| Safety information | |||
|---|---|---|---|
| S Phrase |
S: 22-36 Do not breathe dust. Wear suitable protective clothing. |
||
| R Phrase |
R: 20/21/22-40 Limited evidence of a carcinogenic effect. |
||
